$2.02
0.042.02%
At Close: -
$1.97
-0.05-2.48%
After Hours: Jul 24, 7:50 AM EDT
15 minutes delayed
Comments
Loading...
PharmaCyte Biotech
PMCBNASDAQ
PharmaCyte Biotech (NASDAQ:PMCB) Stock, Guidance And Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
FAQ
What is the most recent guidance for PharmaCyte Biotech (PMCB)?
The last reported Earnings numbers were from July 11, 2022 for the full year 2022 and was for an earnings per share guidance in the range of $-0.27 and $-0.27 versus the estimated EPS of $-0.24.
Browse guidance and forecast on all stocks.